Jean-Michel Bidart

Title: Innovations of Jean-Michel Bidart

Introduction

Jean-Michel Bidart is a notable inventor based in Sceaux, France. He has made significant contributions to the field of cancer research, particularly in the detection of malignant transformations in human cells. With a total of 2 patents, his work has implications for cancer diagnosis and immunotherapy.

Latest Patents

Bidart's latest patents focus on processes for detecting malignant transformations of cells. One of his patents describes a method that involves detecting the overexpression of products from the &bgr;3, &bgr;5, &bgr;8, and &bgr;9 genes, which encode the hCG&bgr; subunit. This detection is relative to their expression in nonmalignant cells. Additionally, he has developed a kit for diagnosing hCG- or hCG fragment-secreting cancers. This kit includes an assembly of polypeptides that cover at least part of the primary sequence of hCG. Furthermore, his patents disclose the use of a polypeptide corresponding to a portion of the primary sequence of hCG for producing a composition useful in hCG- or hCG fragment-secreting cancer immunotherapy.

Career Highlights

Jean-Michel Bidart is affiliated with the Institut Gustave Roussy, a leading cancer research institution. His work has been pivotal in advancing the understanding of cancer biology and improving diagnostic methods.

Collaborations

Some of his notable coworkers include Dominique Bellet and Michel Vidaud. Their collaborative efforts have contributed to the advancements in cancer research and diagnostics.

Conclusion

Jean-Michel Bidart's innovative work in cancer detection and treatment showcases the importance of research in improving healthcare outcomes. His patents reflect a commitment to advancing medical science and enhancing patient care.